{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:53:52Z","timestamp":1760608432117},"reference-count":32,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T00:00:00Z","timestamp":1134086400000},"content-version":"vor","delay-in-days":3752,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1995,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:italic>Objective<\/jats:italic>. To describe liver histopathologic features and ultrastructural changes in a prospectively studied cohort of rheumatoid arthritis (RA) patients receiving long\u2010term methotrexate (MTX) therapy, and to seek correlations between these changes and simultaneously measured laboratory indices of liver function.<\/jats:p><jats:p><jats:italic>Methods<\/jats:italic>. This was a long\u2010term, prospective, open observational study. Twenty\u2010seven outpatients with RA who began therapy with MTX and continued treatment for extended periods underwent baseline and followup liver biopsies. One hundred seventy liver biopsy specimens were analyzed by light microscopy (LM) and assessed according to a modified Roenigk score and a newly devised numerical grading system. Ninety\u2010three biopsy specimens were also analyzed by electron microscopy (EM). Blood samples were obtained at 4\u20136\u2010week intervals for determination of bilirubin, alkaline phosphatase, aspartate aminotransferase (AST), and albumin levels, and the weekly dosage of MTX was adjusted if there were abnormalities in the AST or albumin level. A mean of 6.3 liver biopsies per patient were obtained over a mean followup period of 8.2 years (range 2\u201313 years).<\/jats:p><jats:p><jats:italic>Results<\/jats:italic>. The modified Roenigk score was significantly different from baseline at year 3, when it increased from a mean of 1.8 to 2.3 (<jats:italic>P<\/jats:italic> = 0.05) and at year 6, when it increased to 2.4 (<jats:italic>P<\/jats:italic> = 0.04), but this was not considered clinically meaningful. No other significant changes from baseline were observed by either LM grading system. No significant progression was observed by EM over the course of the investigation. Increases in serial measurements of AST correlated with both the modified Roenigk score (r = 0.21, <jats:italic>P<\/jats:italic> = 0.016) and the numerical rating score (r = 0.19, <jats:italic>P<\/jats:italic> = 0.027).<\/jats:p><jats:p><jats:italic>Conclusion<\/jats:italic>. Patients with RA who are receiving weekly single\u2010dose oral MTX therapy exhibit little deterioration in hepatic architecture by LM or EM when the dosage of the drug is adjusted for abnormalities in AST and serum albumin, monitored at frequent intervals.<\/jats:p>","DOI":"10.1002\/art.1780380904","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T02:03:14Z","timestamp":1171504994000},"page":"1194-1203","source":"Crossref","is-referenced-by-count":53,"title":["Light and electron microscopic analysis of sequential liver biopsy samples from rheumatoid arthritis patients receiving long\u2010term methotrexate therapy followup over long treatment intervals and correlation with clinical and laboratory variables"],"prefix":"10.1002","volume":"38","author":[{"given":"Joel M.","family":"Kremer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gordon I.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy W.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal G.","family":"Ishak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Constantine A.","family":"Axiotis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,9]]},"reference":[{"key":"e_1_2_1_2_2","volume-title":"Textbook of Rheumatology","author":"Harris ED","year":"1993"},{"key":"e_1_2_1_3_2","first-page":"511","article-title":"Liver biopsies from psoriatics related to methotrexate therapy: findings in post\u2010methotrexate liver biopsies from 160 psoriatics","volume":"85","author":"Nyfors A","year":"1977","journal-title":"Acta Pathol Scand"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1980.tb06553.x"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1972.01620060005001"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310301"},{"key":"e_1_2_1_7_2","first-page":"1123","article-title":"Acute reversible hepatic failure associated with methotrexate treatment of rheumatoid arthritis","volume":"16","author":"Clegg DO","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780330717"},{"issue":"9","key":"e_1_2_1_9_2","first-page":"S60","article-title":"Prospective study of hepatotoxicity in patients receiving methotrexate for rheumatoid arthritis (abstract)","volume":"33","author":"Augur NA","year":"1990","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_10_2","first-page":"229","article-title":"Clinical liver disease in rheumatoid arthritis patients on methotrexate","volume":"19","author":"Phillips C","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360307"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780320202"},{"key":"e_1_2_1_13_2","first-page":"189","article-title":"Liver biopsies in patients with rheumatoid arthritis receiving methotrexate: where are we going","volume":"19","author":"Kremer JM","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370304"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/anr.1780321004"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780310302"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780350203"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1949.02900430001001"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0016-5085(19)32478-3"},{"issue":"9","key":"e_1_2_1_20_2","first-page":"S78","article-title":"Electron microscopic analysis of sequential liver biopsies in patients with rheumatoid arthritis on methotrexate (abstract)","volume":"36","author":"Kremer JM","year":"1993","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_21_2","volume-title":"Histocompatibility Testing 1980","author":"Terasaki PI","year":"1980"},{"key":"e_1_2_1_22_2","volume-title":"Diseases of the Liver and Biliary System","author":"Sherlock S","year":"1989"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(86)80075-7"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.14.2.162"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.38.6.501"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009747609099892"},{"issue":"4","key":"e_1_2_1_27_2","first-page":"S18","article-title":"Pretreatment liver histology in rheumatoid arthritis patients treated with low dose methotrexate (abstract)","volume":"29","author":"Tolman KG","year":"1986","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-91-6-877"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.284.6329.1605"},{"key":"e_1_2_1_30_2","first-page":"334","article-title":"Cholestatic jaundice caused by sulindac","volume":"25","author":"Giroux Y","year":"1982","journal-title":"Can J Surg"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780370102"},{"key":"e_1_2_1_32_2","first-page":"57","article-title":"The hepatic extracellular matrix. II. Electron immunohistochemical studies in rats with CCl4\u2010. induced cirrhosis","volume":"53","author":"Martinez\u2010Hernandez A","year":"1984","journal-title":"Lab Invest"},{"key":"e_1_2_1_33_2","first-page":"683","article-title":"Liver involvement in nonamyloid light chain deposits disease","volume":"50","author":"Droz P","year":"1984","journal-title":"Lab Invest"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780380904","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780380904","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T19:18:44Z","timestamp":1700767124000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780380904"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1995,9]]}},"alternative-id":["10.1002\/art.1780380904"],"URL":"https:\/\/doi.org\/10.1002\/art.1780380904","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,9]]}}}